A Randomized, Double‐Blind, Placebo‐Controlled, Parallel Study to Assess the Efficacy and Safety of Once‐A‐Day Tadalafil in Men with Erectile Dysfunction Who Are Naïve to PDE5 Inhibitors

In PDE5 inhibitor‐naïve men, tadalafil once a day significantly improved EF compared with placebo. Safety results were consistent with previous tadalafil once‐a‐day clinical trials. Montorsi F, Aversa A, Moncada I, Perimenis P, Porst H, Barker C, Shane MA, and Sorsaburu S. A randomized, double‐blind, placebo‐controlled, parallel study to assess the efficacy and safety of once‐a‐day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors. J Sex Med 2011;8:2617-2624.